Ocugen Stock Forum

$Ocugen(OCGN.US)$ Chardan Capital pass $4 → $5 Maintains Buy

$Ocugen(OCGN.US)$ A good ride here today

$Ocugen(OCGN.US)$ Ocugen Announces Dosing Completion of Subjects With Geographic Atrophy in Cohort 2 of Phase 1/2 Armada Clinical Trial of Ocu410—a Modifier Gene Therapy

$Ocugen(OCGN.US)$
Ocugen (NASDAQ:OCGN) shares traded higher on Wednesday after the company said that EU regulators agreed to a U.S.-based trial to support a marketing authorization application for the company’s gene therapy candidate, OCU400.
The decision comes after an expert panel of the EU drug regulator, the European Medicines Agency (EMA), reviewed the critical components of the company's Phase 3 liMeliGhT clinical trial for OCU400...

$Ocugen(OCGN.US)$ Ocugen Disclosed Positive Scientific Advice From The European Medicines Agency Related To The Approval Pathway For Ocu400—Modifier Gene Therapy For Broad Retinitis Pigmentosa Indication

$Ocugen(OCGN.US)$ Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
4 MINUTES AGO, 6:30 AM EDT
VIA GLOBENEWSWIRE

$Ocugen(OCGN.US)$ and prepare for liftoff

$Ocugen(OCGN.US)$ Sold half at $1.74 locking in the gains

$Ocugen(OCGN.US)$ Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy
2 MINUTES AGO, 7:02 AM EDT
VIA GLOBENEWSWIRE
• Established Low Dose as Safe and Tolerable Dose in Current OCU410 Clinical Trial
• DSMB Approval to Proceed with Medium Dose Cohort Dosing